Omeros Corporation
Tracked across 1 events · 6 articles · First seen Jul 01, 2026 · Last active Jul 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Omeros Corporation is facing a securities fraud investigation by Pomerantz LLP after its stock price fell significantly due to a negative opinion from the European Union — European Medicines Agency regarding its drug narsoplimab. This event negatively impacts the company's reputation and stock value.
Jul 01, 2026 · 6 articles
100
Pomerantz LLP investigates claims Omeros CorporationPomerantz Investigates...
90
European Union — European Medicines Agency adopted negative opinion Omeros CorporationPomerantz Investigates...
80
Omeros Corporation issued press releasePomerantz Investigates...
ERGEN INTELLIGENCE
Track Omeros Corporation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard